Ir al contenido
· Rellenos dérmicos
SKU 11161 · GTIN 0107640173232261

Teosyal RHA 1

En stock
Volumen
2 x 1 mL
Laboratorio
Teoxane
Origen
Suiza
Indicación
Superficial fine wrinkle correction and broad facial indication range including lips
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Principales ventajas de Teosyal RHA 1

  • Corrects superficial fine wrinkles, skin cracks and depressions
  • Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
  • Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
  • Degree of cross-linking below 5%, with residual BDDE below 1 ppm
  • Mean molecular weight above 1 million Dalton, of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of at least 12 months
Información clave
Marca TEOSYAL
Fabricante Teoxane SA
País de origen Switzerland
Certificación CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Composición Hyaluronic acid of non-animal origin 15 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
Volumen / Tamaño 1 ml
Envase 2 pre-filled syringes x 1 mL, each with 2 sterile 30G 1/2 inch needles and 2 traceability labels
Tipo de uso Professional use only - injectable dermal filler with anaesthetic, for the lips, perioral, periorbital, forehead, midface, neck and décolleté regions
Profundidad de inyección Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protocolo / Duración Estimated duration of effect of at least 12 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Indicaciones y uso profesional

Indicaciones principales

  • Superficial fine wrinkles, skin cracks and depressions
  • Enhancement of skin quality and correction of withered skin marked by signs of ageing

Uso profesional

TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.

Zonas de tratamiento

  • Perioral region: perioral rhytids, lips including the philtrum, oral commissures
  • Upper face: forehead lines
  • Periorbital region: crow's feet, tear trough, eyebrows
  • Midface: smiling lines and accordion lines
  • Neck lines
  • Face, neck and décolleté, for skin quality

Perfil del paciente

For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

Cómo funciona Teosyal RHA 1 ​

TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Por qué comprar en Allpara

Allpara ofrece productos TEOSYAL originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
TEOSYAL
Laboratorio
Teoxane
SKU
11161
GTIN
0107640173232261
Formato
2 x 1 mL
Origen
Suiza
Indicación
Superficial fine wrinkle correction and broad facial indication range including lips
Uso
Professional use only - injectable dermal filler with anaesthetic
/ Detalles del producto

El expediente completo

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Teoxane, país de origen Suiza.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

How does TEOSYAL RHA 1 differ from the rest of the RHA line?
Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
How long does TEOSYAL RHA 1 last?
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
/ FAQ

Preguntas frecuentes

Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

Más productos de Teoxane

Ver laboratorio

TEOXANE referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.

Ver TEOXANE productos

Alternativas para la clínica

Todos los productos

Teosyal RHA 1

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Principales ventajas de Teosyal RHA 1

  • Corrects superficial fine wrinkles, skin cracks and depressions
  • Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
  • Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
  • Degree of cross-linking below 5%, with residual BDDE below 1 ppm
  • Mean molecular weight above 1 million Dalton, of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of at least 12 months
Información clave
Marca TEOSYAL
Fabricante Teoxane SA
País de origen Switzerland
Certificación CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Composición Hyaluronic acid of non-animal origin 15 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
Volumen / Tamaño 1 ml
Envase 2 pre-filled syringes x 1 mL, each with 2 sterile 30G 1/2 inch needles and 2 traceability labels
Tipo de uso Professional use only - injectable dermal filler with anaesthetic, for the lips, perioral, periorbital, forehead, midface, neck and décolleté regions
Profundidad de inyección Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
Protocolo / Duración Estimated duration of effect of at least 12 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

Indicaciones y uso profesional

Indicaciones principales

  • Superficial fine wrinkles, skin cracks and depressions
  • Enhancement of skin quality and correction of withered skin marked by signs of ageing

Uso profesional

TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.

Zonas de tratamiento

  • Perioral region: perioral rhytids, lips including the philtrum, oral commissures
  • Upper face: forehead lines
  • Periorbital region: crow's feet, tear trough, eyebrows
  • Midface: smiling lines and accordion lines
  • Neck lines
  • Face, neck and décolleté, for skin quality

Perfil del paciente

For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

Cómo funciona Teosyal RHA 1 ​

TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Por qué comprar en Allpara

Allpara ofrece productos TEOSYAL originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

Más productos de Teoxane

Ver el laboratorio →

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

Teoxane, país de origen Suiza.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.